The Role of Imaging in Health Screening: Overview, Rationale of Screening, and Screening Economics

Imaging screening examinations are growing in their indications and volume to identify conditions at an early, treatable stage. The Radiology Research Alliance?s ?Role of Imaging in Health Screening? Task Force provides a review of imaging-based screening rationale, economics, and describes established guidelines by various organizations. Various imaging modalities can be employed in screening, and are often chosen based on the specific pathology and patient characteristics. Prevalent disease processes with identifiable progression patterns that benefit from early potentially curative interventions are ideal for screening. Two such examples include colonic precancerous polyp progression to adenocarcinoma in colon cancer formation and atypical ductal hyperplasia progression to ductal carcinoma in situ and invasive ductal carcinoma in breast cancer. Economic factors in imaging-based screening are reviewed, including in the context of value-based reimbursements. Global differences in screening are outlined, along with the role of various organizational guidelines, including the American Cancer Society, the US Preventive Services Task Force, and the American College of Radiology.

Automated summary

Imaging screening plays a crucial role in identifying diseases at an early stage, but the choice of specific screening methods depends on different pathologies and patient characteristics. In addition to economic considerations during the screening process, global differences in screening and guidelines established by various organizations are also key factors affecting the implementation of screening.